A new point-of-care prediction tool that uses clinical and ultrasonography findings has good accuracy for identifying giant cell arteritis among patients seen in fast-track clinics. Investigators ...

older woman holding her head Giant cell arteritis has been vastly studied in white populations; however, its significance among other racial and ethnic groups is not as well known. Giant cell ...

While not used to guide treatment, ESR and CRP typically normalize within two to four weeks after initiating therapy. 2,4 Minor increases in ESR can occur during the prednisone taper, but this does ...

Giant Cell Arteritis: Causes, Symptoms, Diagnosis and Treatment: By Shreoshree Chakrabarty Giant Cell Arteritis, also known as Temporal Arteritis, is an inflammatory condition affecting medium and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A substantial proportion of patients who received ...

The U.S. Food and Drug Administration on Tuesday approved AbbVie Inc.’s (NYSE:ABBV) Rinvoq (upadacitinib), 15 mg, once daily, for giant cell arteritis (GCA). GCA is an inflammation of blood vessels, ...

Results of laboratory studies of thyroid function showed thyrotropin concentration < 0.01 mIU/L, free thyroxine 2.3 ng/L, and T3 uptake 41 with a free triiodothyronine value of 4.5 pg/mL: findings ...

Researchers studied the risk factors for relapse, including prednisolone clearance and glucocorticoid-induced transcript 1 promoter polymorphism (rs37972), in patients with giant cell arteritis.